Back to Candriam S.C.A. Candriam S.C.A.

KRYSKRYS
5 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in Krystal Biotech, Inc.

Candriam S.C.A. previously held 0 shares of KRYS (Krystal Biotech, Inc.), worth $0 as of 2024-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$6.8M

Total Shares Change

-92,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$177.93
0
2023-Q4
Decreased
55,000
-21.4%
$6.8M0.0%$124.06
0
2023-Q3
Unchanged
70,000
0.0%
$8.1M0.1%$116.00
0
2023-Q2
Decreased
70,000
-23.9%
$8.2M0.1%$115.67
0
2023-Q1
New
92,000
-
$6.8M0.0%$79.35
38

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used